View in EDS

Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.

Saved in:
Bibliographic Details
Title: Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Authors: Grivas P; Division of Hematology/Oncology, Department of Medicine, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Garralda E; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Goyal L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Dees EC; Lineberger Comprehensive Cancer Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Bahleda R; Drug Development Department, Institut Gustave Roussy, Villejuif, France., Azad NS; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Karippot A; Cancer Treatment Centers of America, Tulsa, Oklahoma., Kurzrock R; Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, California., Tabernero J; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Kononen J; Docrates Cancer Center, Helsinki, Finland., Ng MCH; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore., Mehta R; GI Medical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Uboha NV; Division of Hematology and Oncology, Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Bigot F; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Angers, France., Boni V; START Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain., Bowyer SE; Linear Clinical Research, Perth, Australia., Breder V; NN Blokhin National Medical Research Center of Oncology, Ministry of Health, Moscow, Russian Federation., Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Chan N; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dhawan M; Division of Hematology and Oncology, University of California, San Francisco, California., Eefsen RL; Department of Oncology, Herlev Gentofte Hospital, Herlev, Denmark., Ewing J; Ironwood Cancer and Research Centers, Scottsdale, Arizona., Graham DM; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway., Won Kim J; Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea., Koynov K; Department of Medical Oncology, MHAT 'Serdika', Sofia, Bulgaria., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea., Redman R; Brown Cancer Center, University of Louisville, Louisville, Kentucky., Yen CJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Spetzler D; Caris Life Sciences, Phoenix, Arizona., Roubaudi-Fraschini MC; Debiopharm International, Lausanne, Switzerland., Nicolas-Metral V; Debiopharm International, Lausanne, Switzerland., Ait-Sarkouh R; Debiopharm International, Lausanne, Switzerland., Zanna C; Debiopharm International, Lausanne, Switzerland., Ennaji A; Debiopharm International, Lausanne, Switzerland., Pokorska-Bocci A; Debiopharm International, Lausanne, Switzerland., Flaherty KT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 15; Vol. 30 (20), pp. 4572-4583.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38771739
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Grivas+P%22">Grivas P</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Garralda+E%22">Garralda E</searchLink>; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Meric-Bernstam+F%22">Meric-Bernstam F</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Mellinghoff+IK%22">Mellinghoff IK</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Goyal+L%22">Goyal L</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Harding+JJ%22">Harding JJ</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Dees+EC%22">Dees EC</searchLink>; Lineberger Comprehensive Cancer Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Bahleda+R%22">Bahleda R</searchLink>; Drug Development Department, Institut Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Azad+NS%22">Azad NS</searchLink>; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Karippot+A%22">Karippot A</searchLink>; Cancer Treatment Centers of America, Tulsa, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Kurzrock+R%22">Kurzrock R</searchLink>; Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Tabernero+J%22">Tabernero J</searchLink>; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Kononen+J%22">Kononen J</searchLink>; Docrates Cancer Center, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Ng+MCH%22">Ng MCH</searchLink>; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Mehta+R%22">Mehta R</searchLink>; GI Medical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Uboha+NV%22">Uboha NV</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.<br /><searchLink fieldCode="AU" term="%22Bigot+F%22">Bigot F</searchLink>; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Angers, France.<br /><searchLink fieldCode="AU" term="%22Boni+V%22">Boni V</searchLink>; START Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bowyer+SE%22">Bowyer SE</searchLink>; Linear Clinical Research, Perth, Australia.<br /><searchLink fieldCode="AU" term="%22Breder+V%22">Breder V</searchLink>; NN Blokhin National Medical Research Center of Oncology, Ministry of Health, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Cervantes+A%22">Cervantes A</searchLink>; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Chan+N%22">Chan N</searchLink>; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.<br /><searchLink fieldCode="AU" term="%22Cleary+JM%22">Cleary JM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Dhawan+M%22">Dhawan M</searchLink>; Division of Hematology and Oncology, University of California, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Eefsen+RL%22">Eefsen RL</searchLink>; Department of Oncology, Herlev Gentofte Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Ewing+J%22">Ewing J</searchLink>; Ironwood Cancer and Research Centers, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Graham+DM%22">Graham DM</searchLink>; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Guren+TK%22">Guren TK</searchLink>; Department of Oncology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Won+Kim+J%22">Won Kim J</searchLink>; Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Koynov+K%22">Koynov K</searchLink>; Department of Medical Oncology, MHAT 'Serdika', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Oh+DY%22">Oh DY</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Redman+R%22">Redman R</searchLink>; Brown Cancer Center, University of Louisville, Louisville, Kentucky.<br /><searchLink fieldCode="AU" term="%22Yen+CJ%22">Yen CJ</searchLink>; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Spetzler+D%22">Spetzler D</searchLink>; Caris Life Sciences, Phoenix, Arizona.<br /><searchLink fieldCode="AU" term="%22Roubaudi-Fraschini+MC%22">Roubaudi-Fraschini MC</searchLink>; Debiopharm International, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Nicolas-Metral+V%22">Nicolas-Metral V</searchLink>; Debiopharm International, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ait-Sarkouh+R%22">Ait-Sarkouh R</searchLink>; Debiopharm International, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zanna+C%22">Zanna C</searchLink>; Debiopharm International, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ennaji+A%22">Ennaji A</searchLink>; Debiopharm International, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pokorska-Bocci+A%22">Pokorska-Bocci A</searchLink>; Debiopharm International, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Flaherty+KT%22">Flaherty KT</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2024 Oct 15; Vol. 30 (20), pp. 4572-4583.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38771739
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-24-0012
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4572
    Titles:
      – TitleFull: Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Grivas P
      – PersonEntity:
          Name:
            NameFull: Garralda E
      – PersonEntity:
          Name:
            NameFull: Meric-Bernstam F
      – PersonEntity:
          Name:
            NameFull: Mellinghoff IK
      – PersonEntity:
          Name:
            NameFull: Goyal L
      – PersonEntity:
          Name:
            NameFull: Harding JJ
      – PersonEntity:
          Name:
            NameFull: Dees EC
      – PersonEntity:
          Name:
            NameFull: Bahleda R
      – PersonEntity:
          Name:
            NameFull: Azad NS
      – PersonEntity:
          Name:
            NameFull: Karippot A
      – PersonEntity:
          Name:
            NameFull: Kurzrock R
      – PersonEntity:
          Name:
            NameFull: Tabernero J
      – PersonEntity:
          Name:
            NameFull: Kononen J
      – PersonEntity:
          Name:
            NameFull: Ng MCH
      – PersonEntity:
          Name:
            NameFull: Mehta R
      – PersonEntity:
          Name:
            NameFull: Uboha NV
      – PersonEntity:
          Name:
            NameFull: Bigot F
      – PersonEntity:
          Name:
            NameFull: Boni V
      – PersonEntity:
          Name:
            NameFull: Bowyer SE
      – PersonEntity:
          Name:
            NameFull: Breder V
      – PersonEntity:
          Name:
            NameFull: Cervantes A
      – PersonEntity:
          Name:
            NameFull: Chan N
      – PersonEntity:
          Name:
            NameFull: Cleary JM
      – PersonEntity:
          Name:
            NameFull: Dhawan M
      – PersonEntity:
          Name:
            NameFull: Eefsen RL
      – PersonEntity:
          Name:
            NameFull: Ewing J
      – PersonEntity:
          Name:
            NameFull: Graham DM
      – PersonEntity:
          Name:
            NameFull: Guren TK
      – PersonEntity:
          Name:
            NameFull: Won Kim J
      – PersonEntity:
          Name:
            NameFull: Koynov K
      – PersonEntity:
          Name:
            NameFull: Oh DY
      – PersonEntity:
          Name:
            NameFull: Redman R
      – PersonEntity:
          Name:
            NameFull: Yen CJ
      – PersonEntity:
          Name:
            NameFull: Spetzler D
      – PersonEntity:
          Name:
            NameFull: Roubaudi-Fraschini MC
      – PersonEntity:
          Name:
            NameFull: Nicolas-Metral V
      – PersonEntity:
          Name:
            NameFull: Ait-Sarkouh R
      – PersonEntity:
          Name:
            NameFull: Zanna C
      – PersonEntity:
          Name:
            NameFull: Ennaji A
      – PersonEntity:
          Name:
            NameFull: Pokorska-Bocci A
      – PersonEntity:
          Name:
            NameFull: Flaherty KT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 10
              Text: 2024 Oct 15
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 20
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1